Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis (Protocol)

Ioannis Gallos; Helen M Williams; Malcom J Price; Abi Merriel; Harold Gee; David Lissauer; Vidhya  Moorthy; Özge  Tunçalp; A Metin  Gülmezoglu; John  Deeks; G Justus  Hofmeyr

doi:10.1002/14651858.CD011689

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis (Protocol)

Ioannis Gallos, Helen M Williams, Malcom J Price, Abi Merriel, Harold Gee, David Lissauer, Vidhya Moorthy, Özge Tunçalp, A Metin Gülmezoglu, John Deeks, G Justus Hofmeyr

Bristol Medical School (THS)

Research output: Contribution to journal › Literature review (Academic Journal) › peer-review

127 Citations (Scopus)

316 Downloads (Pure)

Abstract

This is the protocol for a review and there is no abstract.

The objectives are as follows:
We aim to assess the clinical effectiveness and side-effect profile of uterotonic drugs to prevent PPH, and to generate a clinically useful ranking of available uterotonics according to their effectiveness and side-effects. We will explore the effects according to various key prognostic and treatment factors. The population of interest is women following a vaginal birth or a caesarean section in the hospital or the community setting. All uterotonic drugs considered by theWHO are eligible and the outcomes include blood loss-related outcomes and side-effects.

Original language	English
Journal	Cochrane Database of Systematic Reviews
Issue number	5
DOIs	https://doi.org/10.1002/14651858.CD011689
Publication status	Published - 15 May 2015

Access to Document

10.1002/14651858.CD011689

Gallos_et_al-2015-Cochrane_Database_of_Systematic_ReviewsFinal published version, 250 KB

Handle.net

Persistent link

Uterotonic agents for preventing postpartum haemorrhage: A network meta-analysis
Gallos, I. D., Williams, H. M., Price, M. J., Merriel, A., Gee, H., Lissauer, D., Moorthy, V., Tobias, A., Deeks, J. J., Widmer, M., Tunçalp, Ö., Gülmezoglu, A. M., Hofmeyr, G. J. & Coomarasamy, A., 25 Apr 2018, In: Cochrane Database of Systematic Reviews. 0, 4, 361 p., CD011689.
Research output: Contribution to journal › Review article (Academic Journal) › peer-review

Open Access
File
82 Citations (Scopus)

1080 Downloads (Pure)

Cite this

@article{c1a9408e534c4cf2b73cb1e3331a3875,

title = "Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis (Protocol)",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: We aim to assess the clinical effectiveness and side-effect profile of uterotonic drugs to prevent PPH, and to generate a clinically useful ranking of available uterotonics according to their effectiveness and side-effects. We will explore the effects according to various key prognostic and treatment factors. The population of interest is women following a vaginal birth or a caesarean section in the hospital or the community setting. All uterotonic drugs considered by theWHO are eligible and the outcomes include blood loss-related outcomes and side-effects.",

author = "Ioannis Gallos and Williams, \{Helen M\} and Price, \{Malcom J\} and Abi Merriel and Harold Gee and David Lissauer and Vidhya Moorthy and {\"O}zge Tun{\c c}alp and G{\"u}lmezoglu, \{A Metin\} and John Deeks and Hofmeyr, \{G Justus\}",

year = "2015",

month = may,

day = "15",

doi = "10.1002/14651858.CD011689",

language = "English",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley \& Sons, Ltd.",

number = "5",

}

TY - JOUR

T1 - Uterotonic agents for preventing postpartum haemorrhage

T2 - a network meta-analysis (Protocol)

AU - Gallos, Ioannis

AU - Williams, Helen M

AU - Price, Malcom J

AU - Merriel, Abi

AU - Gee, Harold

AU - Lissauer, David

AU - Moorthy, Vidhya

AU - Tunçalp, Özge

AU - Gülmezoglu, A Metin

AU - Deeks, John

AU - Hofmeyr, G Justus

PY - 2015/5/15

Y1 - 2015/5/15

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: We aim to assess the clinical effectiveness and side-effect profile of uterotonic drugs to prevent PPH, and to generate a clinically useful ranking of available uterotonics according to their effectiveness and side-effects. We will explore the effects according to various key prognostic and treatment factors. The population of interest is women following a vaginal birth or a caesarean section in the hospital or the community setting. All uterotonic drugs considered by theWHO are eligible and the outcomes include blood loss-related outcomes and side-effects.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: We aim to assess the clinical effectiveness and side-effect profile of uterotonic drugs to prevent PPH, and to generate a clinically useful ranking of available uterotonics according to their effectiveness and side-effects. We will explore the effects according to various key prognostic and treatment factors. The population of interest is women following a vaginal birth or a caesarean section in the hospital or the community setting. All uterotonic drugs considered by theWHO are eligible and the outcomes include blood loss-related outcomes and side-effects.

U2 - 10.1002/14651858.CD011689

DO - 10.1002/14651858.CD011689

M3 - Literature review (Academic Journal)

SN - 1469-493X

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 5

ER -

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis (Protocol)

Abstract

Access to Document

Handle.net

Fingerprint

Research output

Uterotonic agents for preventing postpartum haemorrhage: A network meta-analysis

Cite this